Insider · CIK 0001697802

Yi Kathy

Reports to the SEC for 3 companies · RICHMOND, CA

sec.gov

Transactions

Companies

Filings

CIK

0001697802

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-02-14	Theseus Pharmaceuticals, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−3,250 sh	—	—	0
2024-02-14	Theseus Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−99.6K sh	—	—	0
2023-06-13	Theseus Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+19.5K sh	—	—	19,500
2023-06-13	Theseus Pharmaceuticals, Inc.Restricted Stock UnitA Award	Director	AAward	+3,250 sh	—	—	3,250
2022-06-10	Theseus Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2021-10-06	Theseus Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+22.7K sh	—	—	22,678
2021-02-03	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+217K sh	—	—	216,718
2020-10-28	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+78.5K sh	—	—	78,534
2019-05-15	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+5,000 sh	$4.55	+$22.8K	30,512
2019-05-15	SGMOQSANGAMO THERAPEUTICS, INCS Sale	EVP & Chief Financial Officer	SSale	−5,000 sh	$10.00	−$50K	25,512
2019-05-15	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	125,000
2019-04-15	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+5,000 sh	$4.55	+$22.8K	30,512
2019-04-15	SGMOQSANGAMO THERAPEUTICS, INCS Sale	EVP & Chief Financial Officer	SSale	−5,000 sh	$12.11	−$60.6K	25,512
2019-04-15	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	130,000
2019-03-15	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+5,000 sh	$4.55	+$22.8K	30,512
2019-03-15	SGMOQSANGAMO THERAPEUTICS, INCS Sale	EVP & Chief Financial Officer	SSale	−5,000 sh	$10.00	−$50K	25,512
2019-03-15	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	135,000
2019-03-01	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+5,000 sh	$4.55	+$22.8K	30,512
2019-03-01	SGMOQSANGAMO THERAPEUTICS, INCS Sale	EVP & Chief Financial Officer	SSale	−5,000 sh	$10.00	−$50K	25,512
2019-03-01	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	140,000
2019-02-25	SGMOQSANGAMO THERAPEUTICS, INCA Award	EVP & Chief Financial Officer	AAward	+19.3K sh	—	—	25,512
2019-02-25	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right-to-Buy)A Award	EVP & Chief Financial Officer	AAward	+116K sh	—	—	115,500
2019-01-24	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	EVP & Chief Financial Officer	FTax Payment	−988 sh	$11.10	−$11K	6,262
2019-01-15	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+5,000 sh	$4.55	+$22.8K	12,250
2019-01-15	SGMOQSANGAMO THERAPEUTICS, INCS Sale	EVP & Chief Financial Officer	SSale	−5,000 sh	$11.04	−$55.2K	7,250
2019-01-15	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	145,000
2018-12-17	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+5,000 sh	$4.55	+$22.8K	12,250
2018-12-17	SGMOQSANGAMO THERAPEUTICS, INCS Sale	EVP & Chief Financial Officer	SSale	−5,000 sh	$11.44	−$57.2K	7,250
2018-12-17	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	150,000
2018-11-15	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+5,000 sh	$4.55	+$22.8K	12,250
2018-11-15	SGMOQSANGAMO THERAPEUTICS, INCS Sale	EVP & Chief Financial Officer	SSale	−5,000 sh	$10.00	−$50K	7,250
2018-11-15	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	155,000
2018-10-15	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+5,000 sh	$4.55	+$22.8K	12,250
2018-10-15	SGMOQSANGAMO THERAPEUTICS, INCS Sale	EVP & Chief Financial Officer	SSale	−5,000 sh	$13.97	−$69.9K	7,250
2018-10-15	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	160,000
2018-09-17	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+5,000 sh	$4.55	+$22.8K	12,250
2018-09-17	SGMOQSANGAMO THERAPEUTICS, INCS Sale	EVP & Chief Financial Officer	SSale	−5,000 sh	$14.66	−$73.3K	7,250
2018-09-17	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	165,000
2018-08-16	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+5,000 sh	$4.55	+$22.8K	12,250
2018-08-16	SGMOQSANGAMO THERAPEUTICS, INCS Sale	EVP & Chief Financial Officer	SSale	−5,000 sh	$15.39	−$77K	7,250
2018-08-16	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	170,000
2018-07-16	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+5,000 sh	$4.55	+$22.8K	12,250
2018-07-16	SGMOQSANGAMO THERAPEUTICS, INCS Sale	EVP & Chief Financial Officer	SSale	−5,000 sh	$14.77	−$73.9K	7,250
2018-07-16	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	175,000
2018-06-15	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+5,000 sh	$4.55	+$22.8K	12,250
2018-06-15	SGMOQSANGAMO THERAPEUTICS, INCS Sale	EVP & Chief Financial Officer	SSale	−5,000 sh	$15.67	−$78.4K	7,250
2018-06-15	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	180,000
2018-05-15	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+5,000 sh	$4.55	+$22.8K	12,250
2018-05-15	SGMOQSANGAMO THERAPEUTICS, INCS Sale	EVP & Chief Financial Officer	SSale	−5,000 sh	$15.38	−$76.9K	7,250
2018-05-15	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	185,000

Recent filings

Accepted (ET)
Feb 144
Yi Kathy0001104659-24-023581
SEC(opens sec.gov)
Jun 134
Yi Kathy0001745020-23-000039
SEC(opens sec.gov)
Jun 134
Yi Kathy0001104659-22-070663
SEC(opens sec.gov)
Oct 84
Yi Kathy0000899243-21-039758
SEC(opens sec.gov)
Feb 54
Yi Kathy0000899243-21-005091
SEC(opens sec.gov)
Oct 304
Yi Kathy0000899243-20-030033
SEC(opens sec.gov)
May 174
Yi Kathy0001209191-19-031065
SEC(opens sec.gov)
Apr 164
Yi Kathy0001209191-19-024836
SEC(opens sec.gov)
Mar 184
Yi Kathy0001209191-19-020126
SEC(opens sec.gov)
Mar 54
Yi Kathy0001209191-19-017164
SEC(opens sec.gov)

Companies

Address

501 CANAL BLVD POINT RICHMOND TECH CENTER

RICHMOND, CA, 94804